INOVIQ and Promega sign Global EXO-NET Agreement
Filed with ASX · · 2 pages · English
Story so far
Earlier from Inoviq
- Appendix 4D and FY24 Half Year Financial Report
- INOVIQ detects 19% more breast cancers than leading test
- Appendix 4C and Quarterly Activities Report - December 2023
- 2023 AGM CEO Presentation
- Bell Potter Healthcare Conference Investor Presentation
Later from Inoviq
- INOVIQ Investor Update
- Ovarian Cancer Test Validation
- Quarterly Activities Report and Appendix 4C - March 2024
- Breakthrough Exosome Therapy
- INOVIQ completes $7m placement
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq